Incyte CorporationINCY
▲ บวกเงินทุนความเกี่ยวข้อง
StockStory highlights Incyte's strong free cash flow margin, revenue growth, and EPS growth boosted by buybacks, recommending it as a stock to own.
ผลกระทบต่อหุ้น 3
Biotech & Genomic Medicine
Incyte CorporationEnergy Transition & Power Demand
Oceaneering International IncOII
▼ ลบเงินทุนความเกี่ยวข้อง
StockStory flags Oceaneering for stagnating sales, low gross margin, and lack of free cash flow, recommending investors turn it down.
Cloud & Digital Infrastructure
Paycom Software, Inc.PAYC
▼ ลบเงินทุนความเกี่ยวข้อง
StockStory flags Paycom for subpar billings growth, low estimated sales growth, and failure to increase operating margin, recommending investors turn it down.